BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| beta-Gal-Et-N3 | beta-Gal-Et-N3 is an indispensable compound, finding multifarious applications steming from its remarkable utility in exploring the intricate world of glycosylation and galactosyltransferase activity. Possessing an unparalleled chemical architecture, this remarkable compound facilitates the exclusive marking and observation of beta-galactosidase enzymes, thereby significantly contributing to the identification and research of afflictions like cancer and lysosomal storage disorders. Molecular formula: C8H15N3O6. Mole weight: 249.22. |  |
| beta-Gal-TEG-Alkyne | beta-Gal-TEG-Alkyne is a versatile reagent widely used in biomedicine. It serves as a powerful tool for labeling and detecting β-Galactosidase in various biological systems. This product plays a crucial role in studying enzyme pathways, cellular processes, and gene expression. Its application extends to the diagnosis and treatment of diseases associated with abnormal β-Galactosidase levels, such as genetic disorders and cancers. Molecular formula: C15H26O9. Mole weight: 350.36. | |
| beta-Gal-TEG-COOH | beta-Gal-TEG-COOH, an extensively employed specialized compound within the biomedical sector, undeniably holds immense value for the advancement of targeted drug delivery systems. Its exceptional chemical structure renders it an indispensable asset in the realm of research and development. Assumedly, this compound's primary function revolves around its capacity to conjugate drugs or therapeutic molecules, thereby augmenting their stability and solubility. Molecular formula: C15H28O11. Mole weight: 384.38. | |
| beta-Gal-TEG-N3 | beta-Gal-TEG-N3 is a biomedical product that plays a critical role in the field of drug delivery and diagnostics. It is commonly used as a linker molecule for the conjugation of beta-galactosidase enzymes to various drugs and imaging agents. This enables targeted delivery and localization of therapeutic and diagnostic substances for the treatment and detection of specific diseases, including cancers and genetic disorders. Molecular formula: C12H23N3O8. Mole weight: 337.33. | |
| beta-Glc-Bu-COOH | beta-Glc-Bu-COOH is a cutting-edge biomedical compound enigmatically impeding a cohort of key metabolic enzymes implicated in the genesis of metabolic disturbances, e.g., diabetes and obesity. Molecular formula: C11H20O8. Mole weight: 280.27. | |
| beta-Glc-N3 | beta-Glc-N3 is a bioactive substance employed in drug delivery systems designed for studying targeted therapy. beta-galactosonitrile is as it is commonly known, possessing the ability to be fused with pharmaceuticals or biomolecules, thereby augmenting their selectivity and effectiveness in studying ailments like cancer and inflammation. Molecular formula: C8H15N3O6. Mole weight: 249.22. | |
| beta-GlcNAc-N3 | beta-GlcNAc-N3, a remarkable biomedicine, emerges as a groundbreaking solution for a myriad of diseases. Revered as a modified variant of N-acetylglucosamine, this compound assumes a paramount status as a metabolic precursor, fueling the intricate biosynthesis of glycosaminoglycans. Remarkably, the multifaceted properties of beta-GlcNAc-N3 extend beyond the realm of mere treatment. Evidencing its immense potential, it serves as a potent mitigation strategy against inflammation, while simultaneously fostering tissue regeneration. Molecular formula: C10H18N4O6. Mole weight: 290.27. | |
| beta-GlcNAc-TEG-Alkyne | beta-GlcNAc-TEG-Alkyne is a cutting-edge biomedical compound, incorporating a triethylene glycol (TEG) spacer, playing a pivotal role in the researchs for diverse ailments. Being an alkynylated derivative of beta-GlcNAc, this compound unveils invaluable insights into protein glycosylation and its intricate participation in cellular mechanisms. Molecular formula: C17H29NO9. Mole weight: 391.41. | |
| beta-GlcNAc-TEG-COOH | beta-GlcNAc-TEG-COOH is an indispensable constituent in the vibrant biomedical arena, designed to facilitate the amalgamation of curative drugs assiduously designed to counteract inflammatory cascades, autoimmunity as well as pathogenic invasions. Molecular formula: C17H31NO11. Mole weight: 425.53. | |
| beta-GlcNAc-TEG-N3 | beta-GlcNAc-TEG-N3 is an essential compound in the biomedical sphere assuming a pivotal role in the research of glycosylated biomolecules. Pertinently employed as a versatile recompound, it facilitates the incorporation of N-azidoacetylglucosamine (GlcNAc) moieties into diverse compound candidates, aimed at studying diseases encompassing cancer, inflammation and infectious disorders. Molecular formula: C14H26N4O8. Mole weight: 378.73. | |
| beta-Glc-TEG-Alkyne | beta-Glc-TEG-Alkyne is a biomedical compound used in the research of various diseases, including cancer and diabetes. It is a modified carbohydrate compound containing a terminal alkyne group, enabling it to be used in click chemistry reactions. Synonyms: beta-Glc-TEG-Alkyne; HY-151643; CS-0617781. Molecular formula: C15H26O9. Mole weight: 350.36. | |
| beta-Glc-TEG-COOH | beta-Glc-TEG-COOH is an indispensable biomedical compound employed for the research of select ailments, effectively engaging with particular compounds to augment their effectiveness. Molecular formula: C13H24O10. Mole weight: 340.32. | |
| beta-Glc-TEG-N3 | beta-Glc-TEG-N3, a compound widely employed in biomedical research, operates as a chemical linker, facilitating the conjugation of target-specific molecules to diverse pharmaceuticals. This extraordinary versatility empowers the augmentation of drug delivery efficiency, fortifying therapeutic effectiveness in conditions like cancer and inflammatory ailments. Molecular formula: C12H23N3O8. Mole weight: 337.33. | |
| β-Heptaacetylrutinose | β-Heptaacetylrutinose is an intermediate in synthesizing Isorhoifolin, a naturally occurring flavonoid that was shown to exhibit potential antidiabetic, antihyperlipidemic and antioxidant effects. Synonyms: 6-O-(2,?3,?4-Tri-O-acetyl-6-deoxy-α-L-mannopyranosyl)?-β-D-glucopyranose 1,?2,?3,?4-Tetraacetate; β-Heptaacetyl-rutinose. CAS No. 5239-9-8. Molecular formula: C26H36O17. Mole weight: 620.55. | |
| β-Hexaacetylrutinose Bromide | β-Hexaacetylrutinose Bromide is an intermediate in synthesizing Isorhoifolin, a naturally occurring flavonoid that was shown to exhibit potential antidiabetic, antihyperlipidemic and antioxidant effects. Synonyms: β-Hexaacetyl-rutinose Bromide; 6-O-(2,?3,?4-Tri-O-acetyl-6-deoxy-α-L-mannopyranosyl)?-α-D-galactopyranosyl Bromide Triacetate. CAS No. 58947-54-9. Molecular formula: C24H33BrO15. Mole weight: 641.41. | |
| beta-Lac-Bu-COOH | beta-Lac-Bu-COOH, an artificially synthesized compound extensively employed within the biomedicine sector, showcases remarkable competence as an inhibitor for distinct enzymes directly implicated in the amplification and advancement of malignant neoplasms. Molecular formula: C17H30O13. Mole weight: 442.41. | |
| beta-Lac-EO-N3 | beta-Lac-EO-N3, an innovative biomedical product, revolutionizes the therapeutic landscape for bacterial infections. Functioning as a formidable bacteriostatic agent, it dynamically suppresses the proliferation and propagation of deleterious bacteria. Characterized by its distinctive chemical constitution, beta-Lac-EO-N3 exhibits unparalleled proficiency against an extensive spectrum of drug-resistant strains. Molecular formula: C14H25N3O11. Mole weight: 411.36. | |
| beta-Lac-TEG-Alkyne | beta-Lac-TEG-Alkyne is a valuable tool in biomedicine for studying the role of beta-lactamase enzymes in drug resistance. It is widely used in drug discovery and development to identify and characterize new inhibitors for treating antibiotic-resistant bacterial infections. This compound serves as a crucial link in the design and synthesis of potential novel antibiotics, ultimately combating drug resistance and improving patient outcomes. Molecular formula: C21H36O14. Mole weight: 512.5. | |
| beta-Lac-TEG-COOH | beta-Lac-TEG-COOH is an innovative compound, exhibiting remarkable potential in research of cancer and bacterial infections. Functioning as a sophisticated targeted therapeutic vehicle, it exhibits an exceptional capability to achieve efficient and controlled compound liberation while studying detrimental repercussions. Molecular formula: C21H38O16. Mole weight: 546.52. | |
| beta-Lac-TEG-N3 | beta-Lac-TEG-N3, an advanced biomedical agent, renowned for its visionary attributes, serves as a paramount asset in the realm of pharmaceutical exploration and advancement. Seizing upon its exceptional qualities, it emerges as an instrumental aid in scrutinizing and pinpointing diverse disease paradigms including cancer, bacterial infections, and neurological anomalies. Molecular formula: C18H33N3O13. Mole weight: 499.47. | |
| β-Lactosyl Ureide Dihydrate | β-Lactosyl Ureide Dihydrate is used in a noninvasive test to determine orocecal transit time in children, for the understanding and analysis of small intestinal motility. Molecular formula: C13H28N2O13. Mole weight: 420.37. | |
| β-L-Arabinose-1-phosphate (potassium salt) | β -L-Arabinose-1-phosphate (potassium salt) serves as a quintessential substrate in enzymatic assays for the purpose of determining the activity of aldolase. In addition to its application for aldolase assays, it has been subjected to exhaustive investigations for its promising potential in the treatment of Gaucher disease--an intractable lysosomal storage disorder that results from the absence of the enyzme acid beta-glucosidase. Synonyms: 1-O-phosphono-beta-L-arabinopyranose dipotassium salt; beta-L-arabinopyranose 1-(dihydrogen phosphate) dipotassium salt. Molecular formula: C5H9K2O8P. Mole weight: 306.29. | |
| β-Maltose Heptaacetate | β-Maltose Heptaacetate is an protected intermediate of Maltose, a disaccharide commonly found in foods and commonly utilized in brewing processes. Synonyms: β-Maltose 1,2,2',3,3',4',6-Heptaacetate; 4-O-(2,3,4-Tri-O-acetyl-α-D-glucopyranosyl)-β-D-glucopyranose 1,2,3,6-Tetraacetate. CAS No. 7482-60-2. Molecular formula: C26H36O18. Mole weight: 636.55. | |
| beta-Mannachrome | beta-Mannachrome is a cutting-edge biomedical compound, unveiling its significance in research of diabetes. It meticulously gauges and evaluates blood glucose levels with utmost precision and expediency. Its proficiency in impeccably detecting and quantifying the existence of beta-mannachrome enables meticulous monitoring and efficacious research of diabetes. Synonyms: Remazol brilliant blue D-galacto-D-mannan. | |
| beta-Mannachrome A.R. | beta-Mannachrome A.R. is an exquisite biomolecular compound extensively employed in the biomedical realm to study a multitude of allergic disorders, respiratory diseases and autoimmune conditions. This exceptional compound serves as a chromogenic substrate in immunoassays, facilitating precise identification and quantification of distinct enzymes implicated in these pathological phenomena. Synonyms: Remazol brilliant blue D-galacto-D-mannan. | |
| beta-Naphthyl stearate | Beta-Naphthyl Stearate, a chemical compound, is well-known for its utilization as a prime substrate for lipase enzymes and as a quintessential reference compound for mass spectrometry. Along with this, it has also been extensively researched for its implications as a potential biomarker for several detrimental ailments, particularly Alzheimer's disease. CAS No. 6343-74-4. Molecular formula: C28H42O2. Mole weight: 410.63. | |
| β-Phenylethyl β-D-Glucoside Tetraacetate | β-Phenylethyl β-D-Glucoside Tetraacetate is a highly significant compound, extensively employed in the comprehensive research and mitigation of a diverse array of diseases. Its profound antioxidative attributes, coupled with remarkable anti-inflammatory characteristics engender invaluable advantages in the context of prevalent afflictions including cardiovascular ailments, diabetes mellitus and neurodegenerative pathologies. Synonyms: β-Phenylethyl β-D-Glucoside 2,3,4,6-Tetraacetate; 2-Phenylethyl-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside; NSC 231829. CAS No. 76870-87-6. Molecular formula: C22H28O10. Mole weight: 452.45. | |
| β-Rutinose | β-Rutinose can be used as an intermediate in the synthesis of Isorhoifolin (Diosmin EP Impurity C), that is a naturally occurring flavonoid which was shown to exhibit potential antidiabetic, antihyperlipidemic and antioxidant effects. as well as it is an extract from the medicinal plant, Viola tricolor, for the potential treatment of acne. Synonyms: 6-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranose. CAS No. 26184-96-3. Molecular formula: C12H22O10. Mole weight: 326.3. | |
| b-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside | b-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside is a sophisticated compound, functioning as an artfully engineered synthetic glycoside. Thereby, it orchestrates nuanced manipulation of cellular processes instrumental in compound administration, focused therapeutics, or malady identification. Synonyms: Methyl 2-acetamido-2-deoxy-3-O-(b-D-galactopyranosyl)-b-D-galactopyranoside; β-Galactosyl 1-3 N-acetyl galactosamine methyl glycoside; N-Acetyl-3-O-beta-D-galactopyranosyl-beta-D-galactosamine methyl glycoside; N-Acetyl-3-O-β-D-galactopyranosyl-β-D-GA. Grades: ≥98%. CAS No. 88274-25-3. Molecular formula: C15H27NO11. Mole weight: 397.38. | |
| b-Gentiobiose octaacetate | b-Gentiobiose octaacetate is a biomedical compound employed extensively in drug development and research, predominantly recognized as a safeguarding tool for delicate pharmaceuticals. This compound remarkably aids drug delivery and augments stability. Moreover, its application extends to the investigation of ailments such as cancer, diabetes and neurodegenerative disorders, thereby effectively unraveling their intricate mechanisms and potential researchs. Synonyms: 1,2,3,4-Tetra-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)-b-D-glucopyranose. CAS No. 4613-78-9. Molecular formula: C28H38O19. Mole weight: 678.59. | |
| b-Glucosylglycerol 2,3,4,6-tetraacetate | b-Glucosylglycerol 2,3,4,6-tetraacetate, a remarkable compound, exhibits immense potential as an antidiabetic agent. In the realm of diabetes management, this prodigious specimen reigns, adeptly regulating blood glucose levels and fostering insulin sensitivity enhancement. Beyond its primary scope, it gracefully unveils itself as a viable therapeutic alternative for diverse metabolic afflictions. Synonyms: 2-(Tetraacetylglucosido)glycerol; 2-Hydroxy-1-(hydroxymethyl)ethyl b-D-glucopyranoside 2,3,4,6-tetraacetate; 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl glycerol. CAS No. 157024-67-4. Molecular formula: C17H26O12. Mole weight: 422.38. | |
| (+)-Biotin 4-amidobenzoic acid sodium salt | (+)-Biotin 4-amidobenzoic acid sodium salt is a crucial compound used in the biomedical industry. It acts as a precursor for designing novel drugs targeting biotin-dependent enzymes, aiding in the treatment of various disorders related to biotin deficiencies. Synonyms: 4-[[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]benzoic acid sodium salt; N-Biotinyl-p-aminobenzoic acid sodium salt. CAS No. 102418-74-6. Molecular formula: C17H20N3NaO4S. Mole weight: 385.41. | |
| Biotin-dextran MW 10000 | | |
| Biotinoyl Ouabain | Biotinoyl Ouabain is a biotin derivative containing the sugar moiety of ouabain. Molecular formula: C39H58N2O14S. Mole weight: 810.95. | |
| Biotinylated Linear B trisaccharide | Biotinylated Linear B trisaccharide is a biomedical tool used for studying carbohydrate-protein interactions. This compound consists of a linear trisaccharide modified with biotin, which enables specific binding to streptavidin or avidin. It is commonly employed in various biomedical research applications, including the investigation of lectin-carbohydrate recognition, glycan profiling and drug discovery targeting carbohydrate-binding proteins. Molecular formula: C30H49N3O18S. Mole weight: 771.79. | |
| Bis-2',3''-[N-(HABA-CBz)] Bis-6,4'-N-CBz Kanamycin A | Bis-2',3''-[N-(HABA-CBz) Bis-6,4'-N-CBz Kanamycin A is an Amikacin impurity A. Molecular formula: C58H74N6O23. Mole weight: 1223.23. | |
| Bis-3'',5-[N-(HABA-Cbz)] 3,6'-Di(N-benzyloxycarbonyl) Kanamycin A | Bis-3'',5-[N-(HABA-Cbz)] 3,6'-Di(N-benzyloxycarbonyl) Kanamycin A is an impurity of Amikacin, an semi-synthetic aminoglycoside antibotic derived from Kanamycin A. Molecular formula: C58H74N6O23. Mole weight: 1223.23. | |
| b-Lactopyranosyl phenylisothiocyanate | b-Lactopyranosyl phenylisothiocyanate, an invaluable biochemical reagent in the biomedical industry, serves a multifaceted role in detecting glycosylation and elucidating its interaction with proteins. Furthermore, its adaptability in the design of cancer and other glycosylation-related disease treatments further underscores its significance. CAS No. 96324-93-5. Molecular formula: C19H25NO11S. Mole weight: 475.47. | |
| b-Lactose - min 70% b-anomer | b-Lactose - min 70% b-anomer is an esteemed and frequently utilized compound that holds immense significance in the biomedical domain. Utilized predominantly as an excipient in drug formulations, this compound exhibits a minimum of 70% b-anomer. Renowned for its manifold applications in the remediation of diverse ailments such as respiratory disorders, pulmonary anomalies, and select categories of malignancies, this particular variant of b-Lactose stands out. Uses: Sweetening agents. Synonyms: 4-O-(b-D-Galactopyranosyl)-b-D-glucopyranose. CAS No. 5965-66-2. Molecular formula: C12H22O11. Mole weight: 342.30. | |
| b-Lactosyl ureide dihydrate | b-Lactosyl ureide dihydrate is a cutting-edge biomedical compound, profoundly efficacious in research of curbing inflammation and expediting tissue regeneration. It concurrently exudes an extraordinary antimicrobial prowess. Molecular formula: C13H24N2O11 2H2O. Mole weight: 420.37. | |
| Blood group A-BSA (6 atom spacer) | Blood group A-BSA (6 atom spacer), a biomedical diagnostic and therapeutic product, finds application in certain specific blood disorders. Widely used to differentiate and identify A and B blood types, it provides superior accuracy and sensitivity thanks to the 6 atom spacer, which amplifies its clinical value. | |
| Blood Group A-HAS | | |
| Blood group A-HSA | | |
| Blood group A-HSA (6 atom spacer) | Blood group A-HSA (6 atom spacer), a purpose-built protein at the forefront of biomedical discovery and innovation, serves as a fundamental tool in the analysis of ABO(H) blood types. Used extensively in the study of blood transfusion, hematology, and immunology, this product represents a powerful weapon against disease. Its vital role in identifying appropriate blood groups for safe transfusions and treatment of related illnesses cannot be overstated. | |
| Blood Group A-HSA (Globulin Free 6-Atom Spacer) | Blood Group A-HSA (Globulin Free 6-Atom Spacer) is a highly specialized reagent widely employed in the field of blood transfusion medicine. Its primary function is to identify the A antigen in blood samples with remarkable precision, thanks to its 6-atom spacer molecule that enhances both sensitivity and specificity. In a clinical context where just a minor oversight can cause grave harm to the patient, this reagent plays a pivotal role in ensuring that only safe and compatible blood transfusions are performed on individuals with the A blood type. | |
| Blood Group A pentasaccharide | Blood Group A pentasaccharide is a specific carbohydrate molecule commonly used in the biomedical industry for blood typing and transfusion purposes. It is utilized to determine an individual's blood type, specifically Blood Group A. This information is crucial in blood transfusions to ensure compatibility and prevent adverse reactions. Synonyms: GalNAca1-3(Fuca1-2)Galb1-4(Fuca1-3)Glc; blood group A antigen pentaose type 1; D-Glucose, O-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl-(1?3)-O-[6-deoxy-α-L-galactopyranosyl-(1?2)]-O-β-D-galactopyranosyl-(1?4)-O-[6-deoxy-α-L-galactopyranosyl-(1?3)]-; α-D-GalNAc-(1-3)-[α-L-Fuc-(1-2)]-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc; 2-Acetamido-2-deoxy-α-D-galactopyranosyl-(1->3)-[(5S)-5-ethyl-β-D-arabinopyranosyl-(1->2)]-β-D-galactopyranosyl-(1->4)-[(5S)-5-ethyl-β-D-arabinopyranosyl-(1->3)]-D-glucopyranose. Grades: ≥90%. CAS No. 50624-46-9. Molecular formula: C32H55NO24. Mole weight: 837.77. | |
| Blood Group A tetrasaccharide type 5 | Blood Group A tetrasaccharide type 5 is a crucial component specifically targeting and interacting with blood group antigens present on red blood cells with Blood Group A. This tetrasaccharide type 5 is utilized to study and understand the immunogenicity and variation of Blood Group A antigens. Synonyms: GalNAca1-3(Fuca1-2)Galb1-4Glc; Blood Group A tetrasaccharide type V; Blood group A type 5 tetrasaccharide; Alpha-Tetrasaccharide; a-D-GalNAc-(1->3)[a-L-Fuc-(1->2)]-b-D-Gal-(1->4)-D-Glc; O-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl-(1->3)-O-[6-deoxy-a-L-galactopyranosyl-(1->2)]-O-b-D-galactopyranosyl-(1->4)-D-Glucose. Grades: ≥90%. CAS No. 59957-92-5. Molecular formula: C26H45NO20. Mole weight: 691.63. | |
| Blood Group A trisaccharide | Blood Group A Trisaccharide is a trisaccharide compound used in the biomedical industry for blood typing and transfusion medicine. It is specifically designed for treating individuals with blood group A, where it helps determine compatibility for blood transfusions and identify potential antibody reactions. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal; Trisaccharide A; A-trisaccharide hapten; α-D-GalNAc-(1?3)-(α-L-Fuc-[1?2])-D-Gal; 2-Acetamido-2-deoxy-α-D-galactopyranosyl-(1->3)-[6-deoxy-α-L-galactopyranosyl-(1->2)]-D-galactopyranose. Grades: ≥95%. CAS No. 49777-13-1. Molecular formula: C20H35NO15. Mole weight: 529.49. | |
| Blood Group A trisaccharide-APE,Biotin-BSA | Blood Group A trisaccharide-APE is an essential compound used in compound for the detection and identification of blood group A antigens. It acting as a specific probe for identifying individuals with blood type A and plays a crucial role in blood transfusion compatibility testing and forensic investigations. while Biotin-BSA is a valuable compound extensively utilized in the biomedical industry. It serving as an important tool for numerous applications including immunohistochemistry, ELISA assays is and protein labeling. Biotin-BSA conjugates enable the specific detection and visualization of different biomolecules, proteins, or antibodies in various diagnostic and research settings. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-APE-[Biotin]-BSA. | |
| Blood Group A trisaccharide-biotin | Blood Group A trisaccharide-biotin, a biomolecule featuring prominently in carbohydrate-protein interaction research, offers a valuable tool for detecting and isolating carbohydrate-binding proteins like blood group antigens. Its practical functions are particularly significant within the clinical field, like studies involving blood transfusions and blood group polymorphisms. Molecular formula: C39H67N5O18S. Mole weight: 925.42. | |
| Blood Group A trisaccharide-BSA | Blood Group A trisaccharide-BSA is an Invaluable biomedical research tool unraveling the intricate complexities surrounding blood group antigens and their enigmatic interactions. Adopted prevalently within the biomedical research domain, it is used for the research of A antigen in both blood transfusion reactions and the enigma-laden realm of autoimmune diseases. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-BSA. | |
| Blood Group A trisaccharide-(CH2)8COOMe derivative | Blood Group A trisaccharide-(CH2)8COOMe derivative is a synthetic derivative designed to mimic the structure of the Blood Group A trisaccharide antigen. This compound has potential applications in biomedicine, particularly in diagnostic tests and vaccine development for detecting and studying diseases related to Blood Group A antigens. CAS No. 68733-37-9. Molecular formula: C30H53NO17. Mole weight: 699.74. | |
| Blood group A trisaccharide ester derivative | Blood group A trisaccharide ester derivative is a paramount compound employed in biomedical research assuming a pivotal stance in the exploration and comprehension of distinct interactions pertaining to the A antigen prevailing on erythrocytes. Molecular formula: C30H53NO17. Mole weight: 699.74. | |
| Blood Group A trisaccharide, N-aminoethyl nonanamide | Blood Group A trisaccharide, N-aminoethyl nonanamide is an indispensable compound specifically tailored for studying the distinctive requirements of Blood Group A individuals. This compound unfolds a pivotal role in the expedition of blood transfusion drugs. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-b1-O-(CH2)8CONH(CH2)2NH2; Blood group A trisaccharide amine derivative; 9-[[O-2-(Acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1-3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1-2)]-alpha-D-galactopyranosyl]oxy]-N-(2-aminoethyl)nonanamide. Grades: ≥90%. CAS No. 170298-33-6. Molecular formula: C31H57N3O16. Mole weight: 727.79. | |
| Blood group A trisaccharide Sepharose 4B | AFFINIDEXTM-A conjugated to Sepharose 4B via a 10 atom spacer. | |
| Blood Group A Trisaccharide Sepharose FF | AFFINIDEXTM-A conjugated to Sepharose FF via a 10 atom spacer. | |
| Blood Group A trisaccharide, spacer-biotin conjugate | Blood Group A trisaccharide, spacer-biotin conjugate is an indispensable and pivotal instrument in the realm of biomedical research. Its astute design empowers researchers to delve deeper into the intricacies of blood group-related afflictions, granting the ability to discern and apprehend the elusive Blood Group A antigen with utmost precision. Synonyms: Fuc-(a1,2)-[GalNAc-(a1,3)]-b-Gal-O(CH2)3NHCO(CH2)5NH-biotin. CAS No. 870891-83-1. Molecular formula: C39H67N5O18S. Mole weight: 926.04. | |
| Blood group A type 1 linear trisaccharide-NGL | Blood group A type 1 linear trisaccharide-NGL, a carbohydrate of utmost importance, has been considered a potential vaccine candidate for bacterial infections owing to its peculiar interaction mechanism with proteins. Additionally, it tremendously aids the production of glycan microarrays for the screening of carbohydrate-binding proteins, but that's not all. Extensive research and numerous studies have revealed its crucial role in the cancer development and progression. Overall, this trisaccharide definitely deserves to be studied and explored further. | |
| Blood group A type 1 tetrasaccharide-NGL | Blood group A type 1 tetrasaccharide-NGL, a synthetic carbohydrate antigen, boasts of its potential as an effective cancer treatment strategy by selectively targeting and modulating the host immune system. This intriguing tetrasaccharide is capable of thwarting cancer cell metastasis, including in breast and colon cancers. Furthermore, it serves as a principal target agent for engineering glycoconjugate vaccines against bacterial infections caused by certain strains harbouring the infamous ABO blood group antigen. | |
| Blood group A type 2 linear trisaccharide-NGL | Blood group A type 2 linear trisaccharide-NGL is a biomolecule used in the development of blood transfusion protocols and in studying blood group antigen-antibody interactions. It is also an important component for understanding the pathogenesis of infectious diseases like Helicobacter pylori and Campylobacter jejuni that use blood group antigens as receptors. | |
| Blood group A type 2 tetrasaccharide | Blood group A type 2 tetrasaccharide - a complex carbohydrate that adorns the surface of red blood cells of those with blood type A - has been known to interfere with certain human diseases, such as cancer and autoimmune disorders, while simultaneously serving as a mediator for testing and typing blood. Scholars are expeditiously exploring its promising role in targeting disease-related inflammation as a future therapeutic. Synonyms: GalNAca-3(fuca-2)Galb-4GlcNAc; A type 2; blood group A antigen type 2; alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc; 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose; Blood Group A tetrasaccharide type II. Grades: ≥95%. CAS No. 73361-87-2. Molecular formula: C28H48N2O20. Mole weight: 732.68. | |
| Blood group A type 2 tetrasaccharide-NGL | Blood group A type 2 tetrasaccharide-NGL, a carbohydrate antigen indispensable for identifying diversified blood groups, boasts significant potential for cancer research. This tetrasaccharide serves as a robust tool for studying glycosylation changes within cancer cells and diagnosing specific types of tumors. Its therapeutic potential, namely for creating vaccines to fight cancer, has also been explored, rendering it an area of active investigation. | |
| Blood group A type 3/4 linear trisaccharide | Blood group A type 3/4 linear trisaccharide is a biomolecule used in the biomedical industry playing a crucial role in identifying and studying blood group antigens, specifically those associated with blood type A. This trisaccharide is used in the development of drugs and therapies aimed at studying diseases related to blood group phenotypes. Molecular formula: C22H38N2O16. Mole weight: 586.54. | |
| Blood group A type 3/4 tetrasaccharide | Blood group A type 3/4 tetrasaccharide is a synthetic saccharide used in the compound industry for the study and identification of blood group A. It is also utilized in the development of diagnostic tools and assays for detecting ABO antigens in blood typing and transfusion compatibility testing. Molecular formula: C28H48N2O20. Mole weight: 732.68. | |
| Blood group A type 3 linear trisaccharide-NGL | Blood group A type 3 linear trisaccharide-NGL plays an important role in the biomedical industry as it is a potential diagnostic and therapeutic target for cancers, particularly ovarian cancer. It can serve as a biomarker to assess the progression and prognosis of the disease, allowing for earlier detection and more personalized treatment options. Additionally, research has shown that targeting this trisaccharide can lead to improved response to chemotherapy and increased overall survival in ovarian cancer patients. | |
| Blood group A type 3 tetrasaccharide-NGL | Blood group A type 3 tetrasaccharide-NGL is a distinctive glycan molecule that is deployed as a diagnostic tool for deciphering blood group A epitopes on human erythrocytes, as well as a crucial molecule in certain malignant neoplasms and autoimmune maladies in which abnormal blood group antigen expression ensues. Through the analysis of Blood group A type 3 tetrasaccharide-NGL, new insights on glycans' implications in disease and wellbeing have emerged, leading to a more comprehensive understanding of these complex biological macromolecules. | |
| Blood group A type 4 linear trisaccharide-NGL | | |
| Blood group A type 4 tetrasaccharide-NGL | Blood group A type 4 tetrasaccharide-NGL, a glycotope renowned for its utility in exploring carbohydrate antigen-lectin affinities in the biomedical domain, has garnered attention for its putative therapeutic potential in tackling malignancies and cardiovascular malaises. | |
| Blood Group A type III/IV linear trisaccharide | Blood Group A type III/IV linear trisaccharide is a synthetic trisaccharide used in the compound industry for research and development purposes. It specifically targets Blood Group A type III/IV antigens is aiding in the study of blood group-related diseases and blood transfusion compatibility. Synonyms: GalNAca1-3Galb1-3GalNAc. Molecular formula: C22H38N2O16. Mole weight: 586.54. | |
| Blood Group A type II linear trisaccharide | Blood Group A type II linear trisaccharide is an essential biomedical compound acting as an antigen found on red blood cells, playing a crucial role in determining the blood group type A. Synonyms: GalNAca1-3Galb1-4GlcNAc; Blood group A type 2 linear trisaccharide; 2-Acetamido-2-desoxy-β-D-galactopyranosyl-(1->3)-β-D-galactopyranosyl-(1->4)-2-acetamido-2-desoxy-D-glucose; 4-O-[3-O-[2-(Acetylamino)-2-deoxy-beta-D-galactopyranosyl]-beta-D-galactopyranosyl]-2-(acetylamino)-2-deoxy-D-glucose. CAS No. 138398-63-7. Molecular formula: C22H38N2O16. Mole weight: 586.54. | |
Our database is helping our users find suppliers everyday.
